Huakang Biomedical Holdings Company Limited (8622.HK)
HKD 0.18
(1.67%)
HKD 0.18
(1.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -48 Thousand | 1.28 Million | -2.37 Million | -3.92 Million | -3.39 Million | 951 Thousand |
| Net Income | -5.78 Million | -3 Million | -3.9 Million | -11.37 Million | 658 Thousand | 1.24 Million |
| Depreciation & Amortization | 3.17 Million | 3.14 Million | 2.94 Million | 3.19 Million | 2.76 Million | 1.69 Million |
| Deferred income taxes | - | - | - | 2.55 Million | - | - |
| Stock-based compensation | - | - | - | 2.66 Million | - | - |
| Change in working capital | 750 Thousand | 1.57 Million | -1.48 Million | -791 Thousand | -4.59 Million | -1.51 Million |
| Other non-cash items | -366 Thousand | -419 Thousand | 62 Thousand | -167 Thousand | -2.21 Million | -471 Thousand |
| Investing Cash Flow | -1.15 Million | -6.1 Million | -2.05 Million | -1.93 Million | -2.02 Million | -2.45 Million |
| Investments in PPE | -1.5 Million | -811 Thousand | -2.33 Million | -2.08 Million | -2.2 Million | -2.85 Million |
| Acquisitions | - | -1.9 Million | - | -40 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 349 Thousand | -3.39 Million | 276 Thousand | 185 Thousand | 184 Thousand | 394 Thousand |
| Financing Cash Flow | 1.02 Million | 2.32 Million | -1.36 Million | -1.1 Million | -594 Thousand | 36.49 Million |
| Debt repayment | -884 Thousand | -1.28 Million | -1.46 Million | -1.1 Million | -594 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 467 Thousand | 2.3 Million | - | - | - | 43.86 Million |
| Other Financing Activities | 1.44 Million | 1.3 Million | 101 Thousand | -1.1 Million | -594 Thousand | -7.36 Million |
| Accounts receivables | -1.62 Million | -444 Thousand | -533 Thousand | -211 Thousand | 879 Thousand | -2.25 Million |
| Accounts payables | - | 444 Thousand | 533 Thousand | 211 Thousand | -879 Thousand | - |
| Inventory | -489 Thousand | 1.04 Million | -1.63 Million | -63 Thousand | -419 Thousand | -339 Thousand |
| Other working capital | 3.77 Million | 524 Thousand | 148 Thousand | -728 Thousand | -4.17 Million | -1.17 Million |
| Cash at beginning of period | 33.3 Million | 36.2 Million | 41.94 Million | 48.79 Million | 54.79 Million | 19.81 Million |
| Cash at end of period | 32.93 Million | 33.3 Million | 36.2 Million | 41.94 Million | 48.79 Million | 54.79 Million |
| Capital Expenditure | -1.5 Million | -811 Thousand | -2.33 Million | -2.08 Million | -2.2 Million | -2.85 Million |
| Effect of forex changes on cash | -190 Thousand | -405 Thousand | 62 Thousand | 118 Thousand | 4000.00 | - |
| Net cash flow / Change in cash | -368 Thousand | -2.9 Million | -5.73 Million | -6.84 Million | -6 Million | 34.98 Million |
| Free Cash Flow | -1.55 Million | 475 Thousand | -4.7 Million | -6 Million | -5.59 Million | -1.9 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -889.5 Thousand | -889.5 Thousand | -3.28 Million | -5.78 Million | -1.04 Million | -941 Thousand |
| Depreciation & Amortization | 868 Thousand | 868 Thousand | - | 3.17 Million | - | 1.95 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | 750 Thousand | - | - |
| Other non-cash items | -1.38 Million | -1.38 Million | 3.28 Million | -366 Thousand | 1.04 Million | 941 Thousand |
| Investing Cash Flow | -61 Thousand | -61 Thousand | - | -1.15 Million | - | -583.57 Thousand |
| Investments in PPE | - | - | - | -1.5 Million | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -61 Thousand | -61 Thousand | - | 349 Thousand | - | - |
| Financing Cash Flow | 3.44 Million | 3.44 Million | - | 1.02 Million | - | -402.61 Thousand |
| Debt repayment | - | - | - | -884 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | 467 Thousand | - | - |
| Other Financing Activities | 3.44 Million | 3.44 Million | - | 1.44 Million | - | - |
| Accounts receivables | - | - | - | -1.62 Million | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | -489 Thousand | - | - |
| Other working capital | - | - | - | 3.77 Million | - | - |
| Cash at beginning of period | - | - | - | 33.3 Million | - | 37.39 Million |
| Cash at end of period | 1.86 Million | 1.86 Million | - | 32.93 Million | - | 34.67 Million |
| Capital Expenditure | - | - | - | -1.5 Million | - | - |
| Effect of forex changes on cash | -118 Thousand | -118 Thousand | - | -190 Thousand | - | -1.77 Million |
| Net cash flow / Change in cash | 1.86 Million | 1.86 Million | - | -368 Thousand | - | -2.71 Million |
| Free Cash Flow | -1.4 Million | -1.4 Million | - | -1.55 Million | - | 44.1 Thousand |
MGRB
4559
206A
MBX
NWL
SQM-B